Increased cholesterol levels after paroxetine treatment in patients with panic disorder

Jung Kim Eui, Bum Hee Yu

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Panic disorder (PD) is associated with an increased cardiovascular risk. We examined serum cholesterol and plasma catecholamine levels in PD before and after paroxetine treatment. The serum cholesterol and plasma catecholamine levels were not different between the PD patients and control subjects before the treatment. However, the levels of total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol were significantly increased in the 28 PD patients after 3 months of paroxetine treatment, whereas the body mass index and plasma catecholamine levels were unchanged. Paroxetine should be used cautiously for PD patients who have overt or covert cardiovascular disorders.

Original languageEnglish
Pages (from-to)597-599
Number of pages3
JournalJournal of Clinical Psychopharmacology
Volume25
Issue number6
DOIs
StatePublished - Dec 2005

Fingerprint

Dive into the research topics of 'Increased cholesterol levels after paroxetine treatment in patients with panic disorder'. Together they form a unique fingerprint.

Cite this